Press Releases

View Summary Prosensa extends the re-dosing of drisapersen in Europe in patients with Duchenne muscular dystrophy
Sep 26, 2014
PDF 17.8 KB Add to Briefcase
View Summary Prosensa to Present at Upcoming Conferences
Sep 25, 2014
PDF 12.9 KB Add to Briefcase
View Summary Prosensa publishes a sensitive, reproducible and objective methodology for dystrophin analysis in patients with Duchenne muscular dystrophy
Sep 24, 2014
PDF 16.8 KB Add to Briefcase
View Summary Prosensa announces commencement of re-dosing of drisapersen in North America in patients with Duchenne muscular dystrophy
Sep 17, 2014
PDF 25.1 KB Add to Briefcase
View Summary Prosensa announces 12 presentations at the 19th International Congress of the World Muscle Society in Berlin
Sep 9, 2014
PDF 20.5 KB Add to Briefcase
View Summary Prosensa announces Lancet Neurology publication of an exploratory phase II study (DEMAND II) demonstrating efficacy and safety of drisapersen in patients with Duchenne muscular dystrophy
Sep 8, 2014
PDF 20.6 KB Add to Briefcase
View Summary Prosensa to Present at Upcoming Conferences
Sep 3, 2014
PDF 13.0 KB Add to Briefcase
View Summary Prosensa Announces 2nd Quarter 2014 Financial Results and Recent Corporate Developments
Aug 12, 2014
PDF 19.6 KB Add to Briefcase
  Prosensa-resultaten tweede kwartaal 2014 en recente ontwikkelingen
Aug 12, 2014
PDF 227.4 KB Add to Briefcase
View Summary Prosensa and CureDuchenne Strengthen Long-term Collaboration with an Additional [Eur]5M to Advance DMD Pipeline
Aug 11, 2014
PDF 20.1 KB Add to Briefcase
View Summary Prosensa to Present at the Wedbush 2014 Life Sciences Conference
Aug 6, 2014
PDF 12.8 KB Add to Briefcase
View Summary Prosensa Holding N.V. to Webcast Conference Call Discussing 2nd Quarter 2014 Financial Results and Corporate Update on August 12, 2014
Aug 4, 2014
PDF 13.3 KB Add to Briefcase
View Summary Prosensa Files F-3 SEC Mixed Shelf Registration For Up To $150 Million
Jul 7, 2014
PDF 15.0 KB Add to Briefcase
View Summary Prosensa Strengthens its Management Team and Supervisory Board with Key Appointments
Jun 30, 2014
PDF 15.6 KB Add to Briefcase
  Prosensa versterkt Management Team en Raad van Commissarissen
Jun 30, 2014
PDF 346.5 KB Add to Briefcase
View Summary Prosensa Awarded $200,000 Research Grant from PPMD
Jun 27, 2014
PDF 16.8 KB Add to Briefcase
View Summary Prosensa Completes Enrollment in Natural History Study of Duchenne Muscular Dystrophy
Jun 25, 2014
PDF 17.7 KB Add to Briefcase
  Prosensa voltooit rekrutering patiënten in natuurlijke beloopstudie
Jun 25, 2014
PDF 118.4 KB Add to Briefcase
View Summary Prosensa's Hans Schikan Appointed to the Biotechnology Industry Organization's Emerging Companies Section Governing Board
Jun 23, 2014
PDF 14.7 KB Add to Briefcase
View Summary Prosensa to Present at the JMP Securities HealthCare Conference
Jun 19, 2014
PDF 12.8 KB Add to Briefcase
Showing 1-20 of 83 Page: 1 2 3 4 5  Next 20
Add to Briefcase = add release to Briefcase